Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
hormone
|
| gptkbp:ATCCode |
G03BA03
|
| gptkbp:CASNumber |
58-22-0
|
| gptkbp:chemicalFormula |
C19H28O2
|
| gptkbp:class |
anabolic steroid
androgen |
| gptkbp:discoveredBy |
gptkb:Ernst_Laqueur
|
| gptkbp:discoveredIn |
1935
|
| gptkbp:excretion |
kidneys
|
| gptkbp:foundIn |
animals
humans |
| gptkbp:function |
affects bone density
influences libido influences muscle mass regulates male secondary sexual characteristics regulates sperm production |
| https://www.w3.org/2000/01/rdf-schema#label |
Testosteroni
|
| gptkbp:IUPACName |
17β-hydroxyandrost-4-en-3-one
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:meltingPoint |
155 °C
|
| gptkbp:MeSH_ID |
D014 Testosterone
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
288.42 g/mol
|
| gptkbp:predecessor |
gptkb:estradiol
gptkb:dihydrotestosterone |
| gptkbp:producedBy |
adrenal glands
ovaries testes |
| gptkbp:PubChem_CID |
gptkb:DB00624
6013 CHEMBL386630 |
| gptkbp:relatedTo |
gptkb:anabolic_steroids
gptkb:androgens sex hormones |
| gptkbp:routeOfAdministration |
oral
transdermal intramuscular injection |
| gptkbp:sideEffect |
hair loss
acne gynecomastia increased aggression |
| gptkbp:UNII |
3XMK78S47O
|
| gptkbp:usedFor |
hormone replacement therapy
gender-affirming hormone therapy treating hypogonadism |
| gptkbp:bfsParent |
gptkb:Giorgos_Panousopoulos
|
| gptkbp:bfsLayer |
7
|